+
Site Tour

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Watch this compelling session focused on the transcatheter treatment of Mitral and Tricuspid regurgitation. Explore case discussions, including a challenging MitraClip™ procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how their results could influence the treatment of mitral and tricuspid disease in your clinical practice.

Related Videos

Abbott TMTI sponsored symposium at PCRLV 2024

CardioMems™

AV VALVES 2023: Trending Topics – Complexity

AV Valves Summit 2024 | Closing of Day 1

Tendyne™: Animation

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

AV VALVES 2023: Replace, Repair in TR

Luca's testimonial

A decade of Tendyne: C. Klein and P. Denti

TRENDING TOPICS

CS Webinar-Aortic valvular disease management

TaiIored solutions for lifetime management of aortic valvular heart disease

EuroPCR 25 Symposium: MitraClip and TriClip

Enhancing clipping solutions for durable, long-term patient outcomes

Tendyne patient testimonial: Graham's story

Graham’s 10 years journey with Tendyne™ and Dr. Alison Duncan’s Insight

CONNEXT


HUB
RELATED RESOURCES

ACC 2023: COAPT™ trial

2-year outcomes from the TRILUMINATE Pivotal trial

Poster: Primary MR in the Very Elderly

Prognosis of TR after MitraClip for MR

CONNEXT


LIVE
RELATED EVENTS

Navigating the Anatomy | Tricuspid focus

AV VALVES 2023:Decision Making in HF – Mitral

AV VALVES 2023: Replace, Repair in TR

Trending Controversies | AV Valves

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline